Multiple preclinical studies on cell clines and murine models identified molecular targets for MPNST such as EGF and the mTOR signaling pathway with effective in vitro responses to targeted antagonization (Li et al. 2002; Johansson et al. 2008; Endo et al. 2013). Here, MTOR is linked to malignant peripheral nerve sheath tumor.